Scientists race to find best drug sequence for fighting kidney cancer
NCT ID NCT01217931
Summary
This study aims to find the best order to give three existing kidney cancer drugs to patients whose cancer has spread. Researchers are testing six different two-drug sequences to see which order works best to control the disease and is safest. The trial involves 180 patients with advanced kidney cancer who have not yet received these specific types of targeted treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.